{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:08:12Z","timestamp":1794344892826,"version":"4.9.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["Cooperatio Medical Diagnostics"],"award-info":[{"award-number":["Cooperatio Medical Diagnostics"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU21J-03-00019"],"award-info":[{"award-number":["NU21J-03-00019"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["FTN, 00064190"],"award-info":[{"award-number":["FTN, 00064190"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24166-6","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:46:25Z","timestamp":1763415985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Low GATA3 predicts worse survival in penile cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Jan","family":"Hrudka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Prouzov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslav","family":"Mat\u011bj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hojn\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kendall B\u00e1rt\u016f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"\u010capka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette","family":"Zavillov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Waldauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"24166_CR1","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1002\/cam4.4614","volume":"11","author":"X Zhan","year":"2022","unstructured":"Zhan, X., Chen, L., Jiang, M. & Fu, B. Get insight into the cause of death distribution and epidemiology of penile squamous cell carcinoma: A population-based study. Cancer Med. 11, 2308\u20132319 (2022).","journal-title":"Cancer Med."},{"key":"24166_CR2","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1002\/ijc.31194","volume":"142","author":"BT Hansen","year":"2018","unstructured":"Hansen, B. T., Orumaa, M., Lie, A. K., Brennhovd, B. & Nyg\u00e5rd, M. Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956\u20132015. Int. J. Cancer. 142, 1586\u20131593 (2018).","journal-title":"Int. J. Cancer"},{"key":"24166_CR3","first-page":"117","volume":"33","author":"TB Olesen","year":"2022","unstructured":"Olesen, T. B., Sand, F. L., Aalborg, G. L., Munk, C. & Kjaer, S. K. Incidence of penile intraepithelial neoplasia and incidence and survival of penile cancer in Denmark, 1997 to 2018. Cancer Causes Control. 33, 117\u2013123 (2022).","journal-title":"Cancer Causes Control"},{"key":"24166_CR4","doi-asserted-by":"crossref","unstructured":"Brierley, J. D., Gospodarowicz, M. K. & Wittekind, C. TNM Classification of Malignant Tumours (Wiley, 2017).","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"24166_CR5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/his.13429","volume":"72","author":"AL Cubilla","year":"2018","unstructured":"Cubilla, A. L. et al. The world health organisation 2016 classification of penile carcinomas: a review and update from the international society of urological pathology expert-driven recommendations. Histopathology 72, 893\u2013904 (2018).","journal-title":"Histopathology"},{"key":"24166_CR6","unstructured":"Amin, M. B. & Moch, H. Tumours of the penis and scrotum: Introduction. in Urinary and Male Genital Tumours: WHO Classification of Tumours, 5th Edition, Volume 8 362\u2013363IARC Publications, Lyon, (2022)."},{"key":"24166_CR7","doi-asserted-by":"publisher","first-page":"175883592211272","DOI":"10.1177\/17588359221127254","volume":"14","author":"J Chadha","year":"2022","unstructured":"Chadha, J., Chahoud, J. & Spiess, P. E. An update on treatment of penile cancer. Ther. Adv. Med. Oncol. 14, 17588359221127254 (2022).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"24166_CR8","doi-asserted-by":"crossref","unstructured":"Mink, J. N. et al. Evaluation of Prognostic Parameters to Identify Aggressive Penile Carcinomas. Cancers 15, (2023).","DOI":"10.3390\/cancers15194748"},{"key":"24166_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.pathol.2023.03.010","volume":"55","author":"J Hrudka","year":"2023","unstructured":"Hrudka, J. et al. Immune cell infiltration, tumour budding, and the p53 expression pattern are important predictors in penile squamous cell carcinoma: a retrospective study of 152 cases. Pathology 55, 637\u2013649 (2023).","journal-title":"Pathology"},{"key":"24166_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.pathol.2023.10.010","volume":"56","author":"J Hrudka","year":"2024","unstructured":"Hrudka, J. et al. High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases. Pathology 56, 357\u2013366 (2024).","journal-title":"Pathology"},{"key":"24166_CR11","doi-asserted-by":"crossref","unstructured":"Hojn\u00fd, J. et al. Altered TP53, CDKN2A, ATM, EPHA7, POT1, CHEK1, GRIN2A, and EGFR predict shorter survival in penile squamous cell carcinoma. Mod Pathol 100689 (2024).","DOI":"10.1016\/j.modpat.2024.100689"},{"key":"24166_CR12","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","volume":"81","author":"WH Clark Jr","year":"1989","unstructured":"Clark, W. H. Jr et al. Model predicting survival in stage I melanoma based on tumor progression. J. Natl. Cancer Inst. 81, 1893\u20131904 (1989).","journal-title":"J. Natl. Cancer Inst."},{"key":"24166_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000527382","volume":"90","author":"V Reiswich","year":"2023","unstructured":"Reiswich, V. et al. GATA3 expression in human tumors: A tissue microarray study on 16,557 tumors. Pathobiology 90, 219\u2013232 (2023).","journal-title":"Pathobiology"},{"key":"24166_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","volume":"138","author":"H Liu","year":"2012","unstructured":"Liu, H., Shi, J., Wilkerson, M. L. & Lin, F. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am. J. Clin. Pathol. 138, 57\u201364 (2012).","journal-title":"Am. J. Clin. Pathol."},{"key":"24166_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","volume":"38","author":"M Miettinen","year":"2014","unstructured":"Miettinen, M. et al. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am. J. Surg. Pathol. 38, 13\u201322 (2014).","journal-title":"Am. J. Surg. Pathol."},{"key":"24166_CR16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/DAD.0000000000000306","volume":"37","author":"RB Mertens","year":"2015","unstructured":"Mertens, R. B., de Peralta-Venturina, M. N., Balzer, B. L. & Frishberg, D. P. GATA3 expression in normal skin and in benign and malignant epidermal and cutaneous adnexal neoplasms. Am. J. Dermatopathol. 37, 885\u2013891 (2015).","journal-title":"Am. J. Dermatopathol."},{"key":"24166_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/PAI.0000000000000887","volume":"29","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Lu, S., Amin, A. & Wang, L. Coexpress of GATA-3 and ER in anorectal and head and neck squamous cell carcinoma mimicking metastatic breast cancer. Appl. Immunohistochem. Mol. Morphol. 29, 409\u2013413 (2021).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"24166_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.humpath.2023.07.005","volume":"139","author":"SY Zare","year":"2023","unstructured":"Zare, S. Y., Fard, E. V. & Fadare, O. GATA3 immunohistochemistry as a diagnostic adjunct for differentiated vulvar intraepithelial neoplasia: utility and limitations. Hum. Pathol. 139, 55\u201364 (2023).","journal-title":"Hum. Pathol."},{"key":"24166_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/cup.12667","volume":"43","author":"JF Solus","year":"2016","unstructured":"Solus, J. F. et al. Cutaneous squamous cell carcinoma progression is associated with decreased GATA-3 immunohistochemical staining. J. Cutan. Pathol. 43, 347\u2013353 (2016).","journal-title":"J. Cutan. Pathol."},{"key":"24166_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.humpath.2017.02.024","volume":"63","author":"T Hashiguchi","year":"2017","unstructured":"Hashiguchi, T. et al. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma. Hum. Pathol. 63, 157\u2013164 (2017).","journal-title":"Hum. Pathol."},{"key":"24166_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/PAI.0000000000000764","volume":"28","author":"D Agostini-Vulaj","year":"2020","unstructured":"Agostini-Vulaj, D. et al. Incidence and significance of GATA3 positivity in pancreatic ductal adenocarcinoma and cholangiocarcinoma. Appl. Immunohistochem. Mol. Morphol. 28, 460\u2013463 (2020).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"24166_CR22","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1007\/s13577-021-00598-w","volume":"34","author":"AA El-Arabey","year":"2021","unstructured":"El-Arabey, A. A. & Abdalla, M. GATA3 as a regulator for naughty cancer-associated fibroblasts in the microenvironment of high-grade serous ovarian cancer. Hum. Cell. 34, 1934\u20131936 (2021).","journal-title":"Hum. Cell."},{"key":"24166_CR23","doi-asserted-by":"publisher","first-page":"e0156524","DOI":"10.1371\/journal.pone.0156524","volume":"11","author":"T Haraguchi","year":"2016","unstructured":"Haraguchi, T. et al. GATA3 expression is a poor prognostic factor in soft tissue sarcomas. PLoS One. 11, e0156524 (2016).","journal-title":"PLoS One"},{"key":"24166_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/jclinpath-2021-208035","volume":"76","author":"Z Chi","year":"2023","unstructured":"Chi, Z. et al. GATA3 positivity is associated with poor prognosis in patients with oesophageal squamous cell carcinoma. J. Clin. Pathol. 76, 474\u2013479 (2023).","journal-title":"J. Clin. Pathol."},{"key":"24166_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/2211-5463.13532","volume":"13","author":"Y Hu","year":"2023","unstructured":"Hu, Y. et al. Long noncoding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3. FEBS Open. Bio. 13, 195\u2013208 (2023).","journal-title":"FEBS Open. Bio"},{"key":"24166_CR26","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/PAI.0000000000001162","volume":"31","author":"E Vaziri Fard","year":"2023","unstructured":"Vaziri Fard, E., Zare, S. Y. & Fadare, O. GATA3 expression in HPV-associated and HPV-independent vulvar squamous cell carcinomas: patterns of expression and prognostic significance. Appl. Immunohistochem. Mol. Morphol. 31, 661\u2013667 (2023).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"24166_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0925-4773(99)00160-4","volume":"88","author":"F Mueller-Pillasch","year":"1999","unstructured":"Mueller-Pillasch, F. et al. Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech. Dev. 88, 95\u201399 (1999).","journal-title":"Mech. Dev."},{"key":"24166_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/PAP.0000000000000021","volume":"21","author":"Y Gong","year":"2014","unstructured":"Gong, Y., Woda, B. A. & Jiang, Z. Oncofetal protein IMP3, a new cancer biomarker. Adv. Anat. Pathol. 21, 191\u2013200 (2014).","journal-title":"Adv. Anat. Pathol."},{"key":"24166_CR29","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.2147\/OTT.S128810","volume":"10","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. Prognostic value of high IMP3 expression in solid tumors: a meta-analysis. Onco Targets Ther. 10, 2849\u20132863 (2017).","journal-title":"Onco Targets Ther."},{"key":"24166_CR30","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1097\/PAS.0b013e31823272d4","volume":"35","author":"D Lu","year":"2011","unstructured":"Lu, D. et al. IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer. Am. J. Surg. Pathol. 35, 1638\u20131645 (2011).","journal-title":"Am. J. Surg. Pathol."},{"key":"24166_CR31","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.humpath.2014.07.006","volume":"45","author":"Q Wei","year":"2014","unstructured":"Wei, Q. et al. IMP3 expression is associated with poor survival in cervical squamous cell carcinoma. Hum. Pathol. 45, 2218\u20132224 (2014).","journal-title":"Hum. Pathol."},{"key":"24166_CR32","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.3892\/ol.2014.2465","volume":"8","author":"A Takata","year":"2014","unstructured":"Takata, A. et al. Expression of insulin-like growth factor-II mRNA-binding protein-3 as a marker for predicting clinical outcome in patients with esophageal squamous cell carcinoma. Oncol. Lett. 8, 2027\u20132031 (2014).","journal-title":"Oncol. Lett."},{"key":"24166_CR33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/hed.21457","volume":"33","author":"S Li","year":"2011","unstructured":"Li, S. et al. Insulin-like growth factor II mRNA-binding protein 3: a novel prognostic biomarker for oral squamous cell carcinoma. Head Neck. 33, 368\u2013374 (2011).","journal-title":"Head Neck"},{"key":"24166_CR34","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1097\/SCS.0b013e3182319750","volume":"22","author":"HG Li","year":"2011","unstructured":"Li, H. G. et al. IMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinoma. J. Craniofac. Surg. 22, 2022\u20132025 (2011).","journal-title":"J. Craniofac. Surg."},{"key":"24166_CR35","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1600-0714.2011.01019.x","volume":"40","author":"CY Lin","year":"2011","unstructured":"Lin, C. Y. et al. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma. J. Oral Pathol. Med. 40, 699\u2013705 (2011).","journal-title":"J. Oral Pathol. Med."},{"key":"24166_CR36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00432-011-1129-3","volume":"138","author":"KY Kim","year":"2012","unstructured":"Kim, K. Y. & Cha, I. H. Risk stratification of oral cancer patients using a combined prognostic factor including lymph node density and biomarker. J. Cancer Res. Clin. Oncol. 138, 483\u2013490 (2012).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"24166_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-0714.2012.01178.x","volume":"42","author":"TS Clauditz","year":"2013","unstructured":"Clauditz, T. S. et al. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck. J. Oral Pathol. Med. 42, 125\u2013132 (2013).","journal-title":"J. Oral Pathol. Med."},{"key":"24166_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.archoralbio.2016.05.008","volume":"69","author":"YS Hwang","year":"2016","unstructured":"Hwang, Y. S. et al. Insulin-like growth factor-II mRNA binding protein-3 and Podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma. Arch. Oral Biol. 69, 25\u201332 (2016).","journal-title":"Arch. Oral Biol."},{"key":"24166_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0022-5347(05)64836-7","volume":"168","author":"A Lopes","year":"2002","unstructured":"Lopes, A. et al. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J. Urol. 168, 81\u201386 (2002).","journal-title":"J. Urol."},{"key":"24166_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00345-008-0275-y","volume":"27","author":"A Muneer","year":"2009","unstructured":"Muneer, A., Kayes, O., Ahmed, H. U., Arya, M. & Minhas, S. Molecular prognostic factors in penile cancer. World J. Urol. 27, 161\u2013167 (2009).","journal-title":"World J. Urol."},{"key":"24166_CR41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/jclinpath-2011-200429","volume":"65","author":"S Gunia","year":"2012","unstructured":"Gunia, S. et al. Expression of p53, p21 and Cyclin D1 in penile cancer: p53 predicts poor prognosis. J. Clin. Pathol. 65, 232\u2013236 (2012).","journal-title":"J. Clin. Pathol."},{"key":"24166_CR42","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.clgc.2015.12.019","volume":"14","author":"K Zargar-Shoshtari","year":"2016","unstructured":"Zargar-Shoshtari, K. et al. Clinical significance of p53 and p16(ink4a) status in a contemporary North American penile carcinoma cohort. Clin. Genitourin. Cancer. 14, 346\u2013351 (2016).","journal-title":"Clin. Genitourin. Cancer"},{"key":"24166_CR43","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3889\/oamjms.2019.219","volume":"7","author":"FF Prapiska","year":"2019","unstructured":"Prapiska, F. F. & Warli, S. M. P53 and survival rate in penile cancer. Open. Access. Maced J. Med. Sci. 7, 1170\u20131173 (2019).","journal-title":"Open. Access. Maced J. Med. Sci."},{"key":"24166_CR44","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.clgc.2021.07.001","volume":"19","author":"SK Mohanty","year":"2021","unstructured":"Mohanty, S. K. et al. p53 and p16ink4a as predictive and prognostic biomarkers for nodal metastasis and survival in A contemporary cohort of penile squamous cell carcinoma. Clin. Genitourin. Cancer. 19, 510\u2013520 (2021).","journal-title":"Clin. Genitourin. Cancer"},{"key":"24166_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.038","author":"L Elst","year":"2024","unstructured":"Elst, L. et al. Single-cell atlas of penile cancer reveals TP53 mutations as a driver of an aggressive Phenotype, irrespective of human papillomavirus Status, and provides clues for treatment personalization. Eur. Urol. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.038 (2024).","journal-title":"Eur. Urol."},{"key":"24166_CR46","doi-asserted-by":"publisher","unstructured":"Hrudka, J. et al. Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization. Eur Urol. In press (2024). https:\/\/doi.org\/10.1016\/j.eururo.2024.03.038. Eur. Urol. doi:10.1016\/j.eururo.2024.07.029.","DOI":"10.1016\/j.eururo"},{"key":"24166_CR47","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s12253-013-9631-3","volume":"19","author":"G Sun","year":"2013","unstructured":"Sun, G., Hu, W., Lu, Y. & Wang, Y. A meta-analysis of HIF-1\u03b1 and esophageal squamous cell carcinoma (ESCC) risk. Pathol. Oncol. Res. 19, 685\u2013693 (2013).","journal-title":"Pathol. Oncol. Res."},{"key":"24166_CR48","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1007\/s13277-013-1579-0","volume":"35","author":"W Ping","year":"2014","unstructured":"Ping, W., Sun, W., Zu, Y., Chen, W. & Fu, X. Clinicopathological and prognostic significance of hypoxia-inducible factor-1\u03b1 in esophageal squamous cell carcinoma: a meta-analysis. Tumour Biol. 35, 4401\u20134409 (2014).","journal-title":"Tumour Biol."},{"key":"24166_CR49","doi-asserted-by":"publisher","first-page":"e75094","DOI":"10.1371\/journal.pone.0075094","volume":"8","author":"L Gong","year":"2013","unstructured":"Gong, L. et al. Prognostic value of HIFs expression in head and neck cancer: a systematic review. PLoS One. 8, e75094 (2013).","journal-title":"PLoS One"},{"key":"24166_CR50","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12957-017-1163-y","volume":"15","author":"J Zhou","year":"2017","unstructured":"Zhou, J. et al. Clinical and prognostic significance of HIF-1\u03b1 overexpression in oral squamous cell carcinoma: a meta-analysis. World J. Surg. Oncol. 15, 104 (2017).","journal-title":"World J. Surg. Oncol."},{"key":"24166_CR51","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1097\/IGC.0000000000000162","volume":"24","author":"M Huang","year":"2014","unstructured":"Huang, M. et al. Overexpression of hypoxia-inducible factor-1\u03b1 is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis. Int. J. Gynecol. Cancer. 24, 1054\u20131064 (2014).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"24166_CR52","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/modpathol.3880175","volume":"13","author":"P Chu","year":"2000","unstructured":"Chu, P., Wu, E. & Weiss, L. M. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod. Pathol. 13, 962\u2013972 (2000).","journal-title":"Mod. Pathol."},{"key":"24166_CR53","doi-asserted-by":"publisher","first-page":"1243871","DOI":"10.3389\/fonc.2023.1243871","volume":"13","author":"H Hosseinalizadeh","year":"2023","unstructured":"Hosseinalizadeh, H. et al. Emerging insights into keratin 7 roles in tumor progression and metastasis of cancers. Front. Oncol. 13, 1243871 (2023).","journal-title":"Front. Oncol."},{"key":"24166_CR54","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1053\/hupa.2002.129416","volume":"33","author":"P Mhawech","year":"2002","unstructured":"Mhawech, P., Uchida, T. & Pelte, M. F. Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma. Hum. Pathol. 33, 1136\u20131140 (2002).","journal-title":"Hum. Pathol."},{"key":"24166_CR55","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/03936155231224798","volume":"39","author":"J Song","year":"2024","unstructured":"Song, J. et al. Clinical significance of KRT7 in bladder cancer prognosis. Int. J. Biol. Markers. 39, 158\u2013167 (2024).","journal-title":"Int. J. Biol. Markers"},{"key":"24166_CR56","doi-asserted-by":"crossref","unstructured":"Communal, L. et al. A keratin 7 and E-Cadherin signature is highly predictive of Tubo-Ovarian High-Grade serous carcinoma prognosis. Int J. Mol. Sci 22, (2021).","DOI":"10.3390\/ijms22105325"},{"key":"24166_CR57","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.2147\/IJGM.S313584","volume":"14","author":"Y Li","year":"2021","unstructured":"Li, Y., Su, Z., Wei, B. & Liang, Z. KRT7 overexpression is associated with poor prognosis and immune cell infiltration in patients with pancreatic adenocarcinoma. Int. J. Gen. Med. 14, 2677\u20132694 (2021).","journal-title":"Int. J. Gen. Med."},{"key":"24166_CR58","doi-asserted-by":"publisher","first-page":"17863","DOI":"10.1038\/s41598-021-97480-4","volume":"11","author":"J Hrudka","year":"2021","unstructured":"Hrudka, J., Fi\u0161erov\u00e1, H., Jel\u00ednkov\u00e1, K., Mat\u011bj, R. & Waldauf, P. Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma. Sci. Rep. 11, 17863 (2021).","journal-title":"Sci. Rep."},{"key":"24166_CR59","doi-asserted-by":"publisher","first-page":"107327482312149","DOI":"10.1177\/10732748231214936","volume":"30","author":"S Shi","year":"2023","unstructured":"Shi, S. et al. Cytokeratin 7 expression and mismatch repair status for survival prediction in patients with low rectal cancer after neoadjuvant therapy. Cancer Control. 30, 10732748231214936 (2023).","journal-title":"Cancer Control"},{"key":"24166_CR60","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00405-021-06894-3","volume":"279","author":"RSR Woods","year":"2022","unstructured":"Woods, R. S. R. et al. Cytokeratin 7 and 19 expression in oropharyngeal and oral squamous cell carcinoma. Eur. Arch. Otorhinolaryngol. 279, 1435\u20131443 (2022).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"24166_CR61","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/1055-9965.EPI-16-0619","volume":"26","author":"RSR Woods","year":"2017","unstructured":"Woods, R. S. R. et al. Cytokeratin 7 in oropharyngeal squamous cell carcinoma: A junctional biomarker for human Papillomavirus-Related tumors. Cancer Epidemiol. Biomarkers Prev. 26, 702\u2013710 (2017).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"24166_CR62","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12105-017-0874-2","volume":"12","author":"M Mehrad","year":"2018","unstructured":"Mehrad, M., Dupont, W. D., Plummer, W. D. Jr & Lewis, J. S. Jr. Expression and significance of cytokeratin 7, a squamocolumnar junction Marker, in head and neck squamous cell carcinoma. Head Neck Pathol. 12, 448\u2013454 (2018).","journal-title":"Head Neck Pathol."},{"key":"24166_CR63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13000-017-0609-4","volume":"12","author":"H Lee","year":"2017","unstructured":"Lee, H., Lee, H. & Cho, Y. K. Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis. Diagn. Pathol. 12, 18 (2017).","journal-title":"Diagn. Pathol."},{"key":"24166_CR64","doi-asserted-by":"publisher","first-page":"885","DOI":"10.31557\/APJCP.2022.23.3.885","volume":"23","author":"N Alva","year":"2022","unstructured":"Alva, N., Shetty, N. A. S., Mysorker, V. & P. & A study of Cytokeratin-7 expression and clinicopathological correlation in dysplasia and squamous cell carcinoma of the cervix. Asian Pac. J. Cancer Prev. 23, 885\u2013891 (2022).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"24166_CR65","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.21873\/anticanres.13035","volume":"38","author":"DE Lima","year":"2018","unstructured":"Lima, D. E. Expression of CK7 and CDKN2 in cervical intraepithelial neoplasia and correlation with clinical outcome. Anticancer Res. 38, 6673\u20136681 (2018).","journal-title":"Anticancer Res."},{"key":"24166_CR66","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/jog.14108","volume":"45","author":"M Hashiguchi","year":"2019","unstructured":"Hashiguchi, M. et al. Decreased cytokeratin 7 expression correlates with the progression of cervical squamous cell carcinoma and poor patient outcomes. J. Obstet. Gynaecol. Res. 45, 2228\u20132236 (2019).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"24166_CR67","doi-asserted-by":"publisher","first-page":"100250","DOI":"10.1016\/j.modpat.2023.100250","volume":"36","author":"MS Ermakov","year":"2023","unstructured":"Ermakov, M. S., Kashofer, K. & Regauer, S. Different mutational landscapes in human Papillomavirus-Induced and human Papillomavirus-Independent invasive penile squamous cell cancers. Mod. Pathol. 36, 100250 (2023).","journal-title":"Mod. Pathol."},{"key":"24166_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2020-207073","author":"AP Aldera","year":"2021","unstructured":"Aldera, A. P. & Govender, D. Carbonic anhydrase IX: a regulator of pH and participant in carcinogenesis. J. Clin. Pathol. https:\/\/doi.org\/10.1136\/jclinpath-2020-207073 (2021).","journal-title":"J. Clin. Pathol."},{"key":"24166_CR69","first-page":"69","volume":"6","author":"SJA van Kuijk","year":"2016","unstructured":"van Kuijk, S. J. A. et al. Prognostic significance of carbonic anhydrase IX expression in cancer patients: A Meta-Analysis. Front. Oncol. 6, 69 (2016).","journal-title":"Front. Oncol."},{"key":"24166_CR70","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.humpath.2007.10.026","volume":"39","author":"SW Choi","year":"2008","unstructured":"Choi, S. W. et al. Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma. Hum. Pathol. 39, 1317\u20131322 (2008).","journal-title":"Hum. Pathol."},{"key":"24166_CR71","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10006-012-0335-8","volume":"16","author":"AW Eckert","year":"2012","unstructured":"Eckert, A. W., Kappler, M., Schubert, J. & Taubert, H. Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients. Oral Maxillofac. Surg. 16, 189\u2013196 (2012).","journal-title":"Oral Maxillofac. Surg."},{"key":"24166_CR72","doi-asserted-by":"publisher","first-page":"9517","DOI":"10.1007\/s13277-015-3692-8","volume":"36","author":"JS Yang","year":"2015","unstructured":"Yang, J. S. et al. Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma. Tumour Biol. 36, 9517\u20139524 (2015).","journal-title":"Tumour Biol."},{"key":"24166_CR73","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jjco\/hym121","volume":"37","author":"SJ Kim","year":"2007","unstructured":"Kim, S. J. et al. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue. Jpn J. Clin. Oncol. 37, 812\u2013819 (2007).","journal-title":"Jpn J. Clin. Oncol."},{"key":"24166_CR74","doi-asserted-by":"publisher","first-page":"151643","DOI":"10.1016\/j.anndiagpath.2020.151643","volume":"49","author":"C Hu","year":"2020","unstructured":"Hu, C., Wang, H., Lin, L., Sun, X. & Wang, D. Association between carbonic anhydrase 9 expression and poor prognosis in sinonasal squamous cell carcinoma. Ann. Diagn. Pathol. 49, 151643 (2020).","journal-title":"Ann. Diagn. Pathol."},{"key":"24166_CR75","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.urolonc.2011.04.011","volume":"31","author":"Y Zhu","year":"2013","unstructured":"Zhu, Y. et al. Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: a pilot study. Urol. Oncol. 31, 706\u2013711 (2013).","journal-title":"Urol. Oncol."},{"key":"24166_CR76","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13058-020-01284-9","volume":"22","author":"O Mart\u00ednez-S\u00e1ez","year":"2020","unstructured":"Mart\u00ednez-S\u00e1ez, O. et al. Frequency and spectrum of PIK3CA somatic mutations in breast cancer. Breast Cancer res. 22, 45 (2020).","journal-title":"Breast Cancer res."},{"key":"24166_CR77","doi-asserted-by":"publisher","first-page":"921","DOI":"10.5858\/2001-125-0921-CACIPU","volume":"125","author":"J Jiang","year":"2001","unstructured":"Jiang, J. et al. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Arch. Pathol. Lab. Med. 125, 921\u2013923 (2001).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"24166_CR78","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","volume":"18","author":"G Sj\u00f6dahl","year":"2012","unstructured":"Sj\u00f6dahl, G. et al. A molecular taxonomy for urothelial carcinoma. Clin. Cancer Res. 18, 3377\u20133386 (2012).","journal-title":"Clin. Cancer Res."},{"key":"24166_CR79","doi-asserted-by":"publisher","first-page":"14383","DOI":"10.1038\/s41598-018-32569-x","volume":"8","author":"TS Worst","year":"2018","unstructured":"Worst, T. S. et al. CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. Sci. Rep. 8, 14383 (2018).","journal-title":"Sci. Rep."},{"key":"24166_CR80","doi-asserted-by":"publisher","first-page":"210","DOI":"10.20892\/j.issn.2095-3941.2018.0022","volume":"15","author":"MA Estiar","year":"2018","unstructured":"Estiar, M. A. & Mehdipour, P. ATM in breast and brain tumors: a comprehensive review. Cancer Biol. Med. 15, 210\u2013227 (2018).","journal-title":"Cancer Biol. Med."},{"key":"24166_CR81","doi-asserted-by":"crossref","unstructured":"Moslemi, M. et al. The prevalence of ataxia telangiectasia mutated (ATM) variants in patients with breast cancer patients: a systematic review and meta-analysis. Cancer Cell. Int. 21 (474). 2021 (2021).","DOI":"10.1186\/s12935-021-02172-8"},{"key":"24166_CR82","first-page":"2084","volume":"12","author":"YL Chen","year":"2022","unstructured":"Chen, Y. L. et al. Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients. Am. J. Cancer Res. 12, 2084\u20132101 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"24166_CR83","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13058-025-02045-2","volume":"27","author":"Y Gao","year":"2025","unstructured":"Gao, Y. et al. NOTCH1 Inhibition enhances immunogenicity and sensitizes triple-negative breast cancer to immune checkpoint inhibitors. Breast Cancer Res. 27, 92 (2025).","journal-title":"Breast Cancer Res."},{"key":"24166_CR84","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4048\/jbc.2022.25.e15","volume":"25","author":"TK Yoo","year":"2022","unstructured":"Yoo, T. K. et al. Mutational analysis of Triple-Negative breast cancer using targeted Kinome sequencing. J. Breast Cancer. 25, 164\u2013177 (2022).","journal-title":"J. Breast Cancer"},{"key":"24166_CR85","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.humpath.2022.04.006","volume":"125","author":"EC Yoon","year":"2022","unstructured":"Yoon, E. C. et al. TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma. Hum. Pathol. 125, 97\u2013107 (2022).","journal-title":"Hum. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24166-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24166-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24166-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:06:03Z","timestamp":1763417163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24166-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24166"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24166-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that there are no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"40321"}}